The ERBB2 gene (also known as human epidermal growth factor receptor 2 (HER2)) has a critical role in human malignancies, and in about 30 percent of breast cancers, it is exacerbated or overexpressed [48, 49]. This evidence concerns the gene ERBB2 and breast carcinoma.